Behavioral Intervention for CMV in Pregnancy

"Affirmative, according to the information hosted on clinicaltrials.gov this research study is actively searching for participants. This trial was initially posted on November 1st 2021 and last modified on December 6th 2021; as of now there remains a need for 840 individuals at one medical facility."

"This trial requires that applicants are between the ages of 14 and 39. There are 26 studies targeting those under the age of majority, while 37 trials cater to individuals over 65 years old."

"This clinical trial, monitored from the beginning of enrolment until delivery (32 weeks), is designed to evaluate CMV reinfection rates in non-primary infection women. Its secondary goals are to assess the frequency of CMV shedding through PCR analysis on saliva, urine, and blood specimens; measure any changes in self-reported risk behaviours and protective measures with a questionnaire at 12 week post intervention; as well as determine how often new variants of CMV appear via serological screening assays combined with advanced sequencing methods."

"As found on the clinicaltrials.gov website, this medical trial is actively recruiting participants and has been since it was initially published in November 2021; the listing was recently updated in December of that same year."

"This research project is seeking 840 individuals aged between 14 and 39 that have contracted cytomegalovirus. To qualify, applicants must be enrolled in prenatal care before the 20th week of gestation and display CMV seronegative status or a pre-existing maternal infection through high IgG avidity index or a positive CMV IgG with negative immunoglobulin M (IgM)."